Q1 2023 Holdings
Filed 2023-05-15 | 56 holdings | $483.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-08-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $119.5M | 5,161,888 | 24.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $70.8M | 4,519,361 | 14.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $36.8M | 4,598,828 | 7.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $28.0M | 909,579 | 5.8% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $20.7M | 8,459,314 | 4.3% |
| Rain Oncology Inc | COM | 75082Q105 | $19.8M | 2,260,652 | 4.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $16.7M | 686,835 | 3.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $14.7M | 1,620,687 | 3.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $14.0M | 695,001 | 2.9% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $12.9M | 1,409,409 | 2.7% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $10.2M | 2,868,035 | 2.1% |
| Hillevax Inc | COM | 43157M102 | $10.1M | 609,862 | 2.1% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $8.6M | 640,688 | 1.8% |
| Pepgen Inc(PEPG) | COM | 713317105 | $8.0M | 651,050 | 1.6% |
| Sutro Biopharma Inc | COM | 869367102 | $7.7M | 1,675,579 | 1.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $6.5M | 1,693,736 | 1.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $6.2M | 345,293 | 1.3% |
| Dice Therapeutics Inc | COM | 23345J104 | $5.8M | 202,773 | 1.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $5.8M | 470,304 | 1.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.6M | 696,171 | 1.2% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $4.4M | 304,715 | 0.9% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $4.4M | 360,414 | 0.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $4.0M | 80,963 | 0.8% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $3.7M | 1,750,000 | 0.8% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $3.6M | 1,777,251 | 0.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.4M | 495,000 | 0.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $2.9M | 504,407 | 0.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $2.6M | 196,425 | 0.5% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $2.5M | 630,000 | 0.5% |
| Decibel Therapeutics Inc | COM | 24343R106 | $2.4M | 801,629 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.4M | 202,348 | 0.5% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $2.4M | 881,450 | 0.5% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $2.1M | 154,664 | 0.4% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $1.9M | 1,008,437 | 0.4% |
| Elevation Oncology Inc | COM | 28623U101 | $1.6M | 830,565 | 0.3% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $1.5M | 1,049,153 | 0.3% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.4M | 480,000 | 0.3% |
| VTV Therapeutics Inc | CL A | 918385105 | $1.3M | 1,635,509 | 0.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $1.2M | 262,786 | 0.2% |
| Instil BIO Inc | COM | 45783C101 | $1.2M | 1,788,280 | 0.2% |
| Viracta Therapeutics Inc | COM | 92765F108 | $1.1M | 689,709 | 0.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $765.8K | 172,089 | 0.2% |
| Equillium Inc(EQ) | COM | 29446K106 | $449.3K | 615,541 | 0.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $332.5K | 25,000 | 0.1% |
| Allovir Inc | COM | 019818103 | $324.4K | 82,336 | 0.1% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $299.6K | 262,827 | 0.1% |
| Leap Therapeutics IncA | COM | 52187K101 | $287.7K | 846,038 | 0.1% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $256.3K | 883,720 | 0.1% |
| Science 37 Holdings Inc | COM | 808644108 | $253.4K | 900,000 | 0.1% |
| Kala Pharmaceuticals Inc(KALA) | COM NEW | 483119202 | $181.0K | 12,024 | 0.0% |